TLN-232 [158899-10-6]

TargetMol Chemicals

TLN-232 [158899-10-6]

114

Research Use Only

TLN-232

C36H49N9O7S2

783.96

TLN-232, also known as CAP-232, is a synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells.

3 years

C(C=1C=2C(NC1)=CC=CC2)[C@@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H]([C@@H](C)O)C(N)=O)=O)CSSC[C@H](NC([C@@H](CC4=CC=CC=C4)N)=O)C(=O)N3

-20°C

12352200